IRON
Disc Medicine, Inc.- Healthcare
- Biotechnology
- $2.86B market cap
Forecast run · Oct 29, 2026Upside rank 529 of 3,186
Model Signal
ForecastQ Daily Probabilities
44.5%
69.3%
23.5%
Analyst Consensus
Recommendation1.91/5 Buy
Last price$74.51
Price target$127.14
Implied move+70.6%
Analysts11
ForecastQ Portfolios
IRON is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.